When I first started at IRI-Sys, my focus was on building tools for formula and ingredient compliance. I (incorrectly) thought that was the complexity of developing a product. Labels felt like the easy part, just put the name, a creative design on the product and you’re good to go…

Conversations with customers quickly revealed all the bottlenecks that can derail launches, and how a surprising amount of it lives in the label review process. Learning about it has been equal parts eye-opening and frustrating because with the technology available today, this problem is solvable, and for most companies, it isn't being solved.

To have a compliant and market-ready label, you need to ensure specific panel placement, font size minimums, INCI naming conventions, claims language rules, warning formats, etc. Get any one of these wrong and the product is technically misbranded under law and you (as the brand) could get in BIG trouble.

The asymmetric risk here is scary.

A misplaced INCI name or a font two points too small can be the result of honest mistakes, but they carry the same legal weight as a major violation. What follows can be an FDA warning letter, a recall, a re-labeling run, or a delayed launch. Not fun.

The way most brands handle this today: someone opens a label and cross-references a spreadsheet, or sends artwork to an external consultant and waits for feedback.

The loop is slow, breaking at the handoff between creative, regulatory, and ops. Errors can slip through because the process wasn't built for the speed modern brands need. The human expert at the end of that process is still essential, but too much of their time goes toward catching things that should never have made it to their desk.

I believe the companies that will define the next decade are the ones with the tightest feedback loops, and that advantage compounds.

A brand that can go from idea to shelf in weeks rather than months can release more products, adapt to trends, and enter more markets. Label review is an invisible bottleneck, and an AI-first approach to label reviews can strip out the catchable errors before the expert ever sees the label, so their review is sharper and focused on the judgment calls that actually require it.

The Label Review tool we just launched at IRI-Sys is free, designed to be that first-pass check before errors make it into a print run or a customs declaration.

If you're launching a product or want to gut-check a label before it goes to print, shoot me a message ([email protected]) or use the link below.

I hope you are hungry for some finance beauty news.

This edition, capital kept chasing the person behind the product.

L Catterton (a PE powerhouse lately focusing more and more on the beauty industry) made two founder-led bets in a single month, backing a dermatologist with 20m followers and a celebrity hairstylist.

In the meantime, Jay-Z's fund circled Rihanna's Fenty.

At the other end, the big houses kept pruning: L'Oréal leaned into India, Estée Lauder shopped its laggards, and Glossier reached for a credit line.

Let’s dive in:

L Catterton led a $19m Series A in Remedy, a skincare brand, with seed lead Norwest and new investor Sonoma Brands Capital joining.

The company was founded by dermatologist Dr. Muneeb Shah, whose skincare content has 20m+ followers, and sells across DTC, Amazon, TikTok Shop, and Target. Learn more.

Berlin Packaging acquired two packaging suppliers: New Jersey's O.Berk and UK-based BlueSky. Terms were not disclosed for either deal. The acquisitions expand its beauty and personal care packaging reach across North America and EMEA. Learn more.

Betaworks and True Ventures backed a $2m seed round for Patina, a fragrance tech startup.

It is building Sense1, an AI model that designs new scent molecules at the olfactory receptor level per TechCrunch.

L'Oréal (Paris: OR) agreed to buy a majority stake in Innovist, an Indian personal care company behind Bare Anatomy and Chemist at Play.

Terms were not disclosed; the founders stay on as minority holders, L'Oréal has rights to buy them out in full, and the brands join its Consumer Products Division. Learn more.

A syndicate of 14 angel investors put $1.5m into Fascent, a French fragrance brand, in its first outside round. The capital funds U.S. expansion, where the brand sells at Revolve, Luckyscent, Credo, and Arielle Shoshana per Beauty Independent.

L Catterton took a significant minority stake in Rōz, a haircare brand from celebrity hairstylist Mara Roszak, with existing investors Silas Capital and G9 Ventures joining.

Terms were not disclosed; 2026 revenue is projected anywhere from $20m to $35m across reports. It is L Catterton's second founder-led bet of the month after Remedy per Beauty Independent.

Woodline Partners and GordonMD Global Investments co-led a $20m Series A in Rapalogix Health, a skincare biotech spun out of Cambrian Bio. Learn more.

Jay-Z's MarcyPen Capital Partners is the reported frontrunner to buy LVMH's (Paris: MC) 50% stake in Fenty Beauty. LVMH has run the sale via Evercore since October, holding the stake through Kendo Brands.

Fenty posted roughly $450m in 2024 net sales at a reported $1B to $2B valuation. A deal would make MarcyPen ($1.1B AUM) co-owner alongside Rihanna, who holds the other half per Beauty Independent.

The Founders, the Korean incubator behind Anua, is reportedly exploring a buy of Dr. Jart+ from Estée Lauder (NYSE: EL). Dr. Jart+ is part of a three-brand auction alongside Too Faced and Smashbox.

Sales have slid to ~$121m (down 23% YoY) versus the ~$1.7B ELC valued it at in 2019. Learn more.

Capsum acquired KKT Labs, an Orlando-based clean-beauty and biotech formulation lab. Terms were not disclosed.

KKT founder Krupa Koestline becomes CEO of Capsum USA and is relocating the lab's resources to Capsum's Austin facility. Capsum projects the move could quadruple its U.S. revenue to $70m to $100m within four to five years. Learn more.

Tiger Finance provided Glossier a $45m non-dilutive revolving credit line. The capital backs a turnaround under new CEO Colin Walsh (ex-P&G), who is closing nine of 12 stores and cut roughly a third of staff this year. Glossier last raised $80m in equity in 2021. Learn more.

Seven Seven Six led a $7m seed round in Halo, a textured-hair tech startup, with AlleyCorp and Bling Capital joining.

Its first device, HaloBraid, lets stylists braid up to five times faster per TechCrunch.